Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
Shiqi Li,Yi Zhu,Zhen Liang,Xiao Wang,Shuai Meng,Xin Xu,Xianglai Xu,Jian Wu,Alin Ji,Zhenghui Hu,Yiwei Lin,Hong Chen,Yeqing Mao,Wei Wang,Xiangyi Zheng,Ben Liu,Liping Xie
DOI: https://doi.org/10.18632/oncotarget.10575
2016-01-01
Oncotarget
Abstract:Despite the recent studies which have shown that microRNA (miRNA) negatively regulates gene expression by silencing the expression of target genes, here we reported the new evidence of microRNA-mediated gene activation by targeting specific promoter sites. We identified a miR-877-3p binding site on the promoter site of tumor suppressor gene p16 which alters frequently in bladder cancer. Enforced expression of miR-877-3p could increase the expression of p16, which inhibit the proliferation and tumorigenicity of bladder cancer through cell cycle G1-phase arrest. Further evidences confirmed that the correlation between p16 activation and miR-877-3p was due to the direct binding. These findings demonstrate the anti-tumor function of miR-877-3p in bladder cancer cells and reveal a new pattern of miRNA involved gene regulation.